Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Ransohoff

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2007
Data sources for measuring colorectal endoscopy use among Medicare enrolleesAnna P Schenck, Carrie N Klabunde, Joan L Warren, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2008
Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among medicare enrollees in fee for serviceAnna P Schenck, Carrie N Klabunde, Joan L Warren, et al.
Nature Reviews. Clinical Oncology|March 3, 2011
Biomarker studies: a call for a comprehensive biomarker study registryFabrice Andre, Lisa M McShane, Stefan Michiels, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2013
Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps vary on the basis of centerShannon R Payne, Timothy R Church, Michael Wandell, et al.
The New England Journal of Medicine|March 21, 2014
Multitarget stool DNA testing for colorectal-cancer screeningThomas F Imperiale, David F Ransohoff, Steven H Itzkowitz, et al.
The New England Journal of Medicine|January 20, 2012
Bone-density testing interval and transition to osteoporosis in older womenMargaret L Gourlay, Jason P Fine, John S Preisser, et al.
Annals of Internal Medicine|January 7, 2015
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaborationKarel G M Moons, Douglas G Altman, Johannes B Reitsma, et al.
The Lancet. Oncology|May 9, 2014
Addressing overdiagnosis and overtreatment in cancer: a prescription for changeLaura J Esserman, Ian M Thompson, Brian Reid, et al.
Gastrointestinal Endoscopy|November 26, 2002
National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002Sidney Cohen, Bruce R Bacon, Jesse A Berlin, et al.
Gut|February 15, 2013
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancerTimothy Robert Church, Michael Wandell, Catherine Lofton-Day, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2007
Data sources for measuring colorectal endoscopy use among Medicare enrolleesAnna P Schenck, Carrie N Klabunde, Joan L Warren, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2008
Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among medicare enrollees in fee for serviceAnna P Schenck, Carrie N Klabunde, Joan L Warren, et al.
Nature Reviews. Clinical Oncology|March 3, 2011
Biomarker studies: a call for a comprehensive biomarker study registryFabrice Andre, Lisa M McShane, Stefan Michiels, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2013
Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps vary on the basis of centerShannon R Payne, Timothy R Church, Michael Wandell, et al.
The New England Journal of Medicine|March 21, 2014
Multitarget stool DNA testing for colorectal-cancer screeningThomas F Imperiale, David F Ransohoff, Steven H Itzkowitz, et al.
The New England Journal of Medicine|January 20, 2012
Bone-density testing interval and transition to osteoporosis in older womenMargaret L Gourlay, Jason P Fine, John S Preisser, et al.
Annals of Internal Medicine|January 7, 2015
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaborationKarel G M Moons, Douglas G Altman, Johannes B Reitsma, et al.
The Lancet. Oncology|May 9, 2014
Addressing overdiagnosis and overtreatment in cancer: a prescription for changeLaura J Esserman, Ian M Thompson, Brian Reid, et al.
Gastrointestinal Endoscopy|November 26, 2002
National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002Sidney Cohen, Bruce R Bacon, Jesse A Berlin, et al.
Gut|February 15, 2013
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancerTimothy Robert Church, Michael Wandell, Catherine Lofton-Day, et al.
Pageof 11